NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82

Posted on:17 Mar 2016 09:14:27
NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82
17 March 2016 Current Affairs: The National Research Development Corporation (NRDC) on 16 March 2016 signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an Ayurvedic formulation for prevention and management of diabetes.The agreement will now allow Kudos Laboratories India to commercialize the drug under their trade name with due acknowledgement to Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India.Ayush-82 was developed by CCRAS. The CCRAS is an apex organization for research in Ayurveda under the Ministry of AYUSH. Kudos Laboratories India, a 100 years old organization, is engaged in marketing, manufacturing and exports of the widest range of Ayurvedic / Herbal products and range of Cosmetics.The company holds G.M.P & ISO Certifications.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs 2018 June

24 JUNE
NEWS
23 JUNE
NEWS
22 JUNE
NEWS
21 JUNE
NEWS

Current Affairs 2018 May

31 MAY
NEWS
30 MAY
NEWS
29 MAY
NEWS
28 MAY
NEWS

Current Affairs 2018 April

30 APRIL
NEWS
29 APRIL
NEWS
28 APRIL
NEWS
27 APRIL
NEWS